1. Back to Outputs Catalog

PTPA variants and the risk for Parkinson’s disease in diverse ancestry populations

July 19, 2023

Training and Networking Working Group

PTPA variants and the risk for Parkinson's disease in diverse ancestry populations

View Article

Letter to the editor regarding an article by Fevga and colleagues1 delineating the role of bi-allelic variants in the PTPA gene (OMIM *600756) and their association with autosomal recessive early-onset parkinsonism and intellectual disability (ID).

Training and Networking Working Group

The Training and Networking working group promotes training and networking throughout the GP2 project.
Learn more about Training and Networking Working Group

Meet the authors

PhD student/Neurological resident, Honorary Research Assistant

Miriam Ostrožovičová, MD

University of Pavol Jozef Šafárik, University College London | Kosice, Slovakia

Neurology Consultant

Yasser Mecheri, MD,MSc

Centre Hospitalo-Universitaire Dr Benbadis Constantine | Constantine, Algeria

Senior Clinical Scientist participating as a Cohort PI

Bashayer Al Mubarak, PhD

King Faisal Specialist Hospital and Research Center | Saudi Arabia

Unknown, Researcher

Nada Abdullah Altassan, PhD

Unknown, King Faisal Specialist Hospital and Research Center | Saudi Arabia

Biomedical Data Scientist, Contractor

Mary B Makarious, PhD

National Institutes of Health | Washington D.C., USA

Postdoctoral research fellow, Visiting research fellow

Maria Teresa Periñan, PhD

Instituto de Biomedicina de Sevilla | Seville, Spain

Staff Scientist

Sara Bandres-Ciga, PharmD,PhD

National Institutes of Health | USA

More outputs and publications

Towards a Global View of Parkinson's Disease Genetics
Description Parkinson\’s disease (PD) is a global health challenge, yet historically studies of PD have taken place predominantly in European populations. Recent genetics research conducted in non-European populations has revealed novel population-specific genetic loci linked to PD risk, highlighting the importance of studying PD globally. These insights have broadened our understanding of PD etiology, which […]
Read More
Mendelian Randomization and Parkinson's Disease
Description Integrative Omics in Parkinson’s Disease provides a comprehensive understanding of the current literature on high-throughput technologies relating to discoveries for Parkinson\’s disease etiology. This emerging field uses large omics datasets to investigate the etiology of Parkinson’s disease and other forms of parkinsonism. The book traces the evolution of omics technologies from the discovery of […]
Read More
Is SH3GL2 p.G276V the Causal Functional Variant Underlying Parkinson's Disease Risk at this Locus?
We read with great interest the article by Bademosi and colleagues, where they investigated the role of SH3GL2 p.G276V on neuron dysfunction in Parkinson's disease (PD).
Read More